# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Follicular Lymphoma

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 178 results.
A Pilot Study of a Personalized Neoantigen Cancer Vaccine Following Front-Line Rituximab in Follicular Lymphoma
Status: Not yet recruiting
Last Changed: Apr 24, 2020
First Received: Dec 05, 2017
Disease(s): Follicular Lymphoma
Intervention(s): Rituximab, Neo Vax
Locations: Dana Farber Cancer Institute, Boston, Massachusetts, United States
TGR1202 in Relapsed and Refractory Follicular Lymphoma
Status: Recruiting
Last Changed: Jul 26, 2019
First Received: Jun 06, 2017
Disease(s): Follicular Lymphoma
Intervention(s): TGR-1202
Locations: Columbia University Medical Center, New York, New York, United States
Idelalisib+Obinutuzumab in Patients With Relapsed/Refractory Follicular Lymphoma
Status: Recruiting
Last Changed: Dec 02, 2019
First Received: Mar 26, 2019
Disease(s): Follicular Lymphoma
Intervention(s): Idelalisib, Obinutuzumab
Locations: Centro Riferimento Oncologico - S.O.C. Oncologia Medica A, Aviano, Italy
IRCCS Istituto Tumori Giovanni Paolo II - U.O.C Ematologia, Bari, Italy
Policlinico S.Orsola-Malpighi - Istituto di Ematologia "Seragnoli", Bologna, Italy
ASST Spedali Civili di Brescia - Ematologia, Brescia, Italy
Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia, Firenze, Italy
... and 8 other locations.
Compare the Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma (FLINTER)
Status: Recruiting
Last Changed: Apr 09, 2020
First Received: Jun 05, 2019
Disease(s): Follicular Lymphoma
Intervention(s): DRL_RI (Proposed rituximab biosimilar), MabThera®
Locations: Rcca Md Llc, Bethesda, Maryland, United States
University Cancer & Diagnostic Centers, Houston, Texas, United States
Bendamustine in Combination With Rituximab as a First-line Therapy Followed by Maintenance Therapy With Rituximab in Patients With Follicular Lymphoma
Status: Recruiting
Last Changed: Apr 22, 2015
First Received: Apr 22, 2015
Disease(s): Follicular Lymphoma
Intervention(s): Rituximab, bendamustine
Locations: National Research Center for Hematology, Moscow, Russian Federation
Rituximab With or Without Ibrutinib for Patients With Advanced Follicular Lymphoma
Status: Recruiting
Last Changed: Feb 19, 2020
First Received: May 21, 2015
Disease(s): Follicular Lymphoma
Intervention(s): Ibrutinib, Rituximab
Locations: Akademisches Lehrkrankenhaus Feldkirch, Feldkirch, Austria
Aalborg Universitetshospital, Aalborg, Denmark
Aarhus University Hospital, Aarhus, Denmark
Rigshospitalet, Copenhagen, Denmark
Odense Universitetshospital, Odense C, Denmark
... and 38 other locations.
Clonal Evolution in Follicular Lymphoma
Status: Recruiting
Last Changed: May 20, 2020
First Received: Jun 19, 2017
Disease(s): Follicular Lymphoma
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma
Status: Recruiting
Last Changed: May 14, 2020
First Received: Jun 26, 2018
Disease(s): Follicular Lymphoma
Intervention(s): tisagenlecleucel
Locations: City of Hope National Medical Center Dept.ofCityofHopeMedicalCtr(1), Duarte, California, United States
UCSF Medical Center, San Francisco, California, United States
H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
University of Chicago Medical Center Hematology and Oncology, Chicago, Illinois, United States
University of Kansas Hospital and Medical Center DeptofUofKansas CancerCenter-2, Kansas City, Kansas, United States
... and 28 other locations.
RITUXIMAB + IMMUNOTHERAPY IN FOLLICULAR LYMPHOMA
Status: Recruiting
Last Changed: Apr 24, 2020
First Received: Aug 17, 2018
Disease(s): Follicular Lymphoma
Intervention(s): Rituximab, Utomilumab, Avelumab, PF04518600
Locations: City of Hope, Duarte, California, United States
Emory University, Atlanta, Georgia, United States
University of Chicago, Chicago, Illinois, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Washington University in St. Louis, Saint Louis, Missouri, United States
... and 1 other locations.
Untreated FolliculaR Lymphoma Treated With OBinituzumAb in a Non-interventional Study (URBAN)
Status: Recruiting
Last Changed: May 21, 2020
First Received: Jul 26, 2019
Disease(s): Follicular Lymphoma
Intervention(s): Obinutuzumab
Locations: Ospedale Civile Dello Spirito Santo; Divisione Di Ematologia, Pescara, Abruzzo, Italy
Azienda Ospedaliera Bianchi-Melacrino-Morelli; Unità Operativa di Ematologia, Reggio Calabria, Calabria, Italy
Azienda Ospedaliera S.G. Moscati; Divisione Ematologia, Avellino, Campania, Italy
Asl ce - p.o. Avers; Uoc ematologia, Aversa, Campania, Italy
A.O. S. Anna e San Sebastiano, Caserta, Campania, Italy
... and 44 other locations.